Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459687
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-03
Brief Title:
Phase III Study of Socazolimab as First-Line Treatment in Persistent Recurrent or Metastatic Cervical Cancer
Sponsor:
Lees Pharmaceutical Limited
Organization:
Lees Pharmaceutical Limited
Organization Data
Organization:
Lees Pharmaceutical Limited
Class:
INDUSTRY
Study ID:
ZKAB001-LEES-2024-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lees Pharmaceutical Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None